Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis

Sponsor
University of Rochester (Other)
Overall Status
Completed
CT.gov ID
NCT01683799
Collaborator
National Institute on Aging (NIA) (NIH)
48
1
2
42
1.1

Study Details

Study Description

Brief Summary

The purpose if the study is to determine whether improving sleep, especially slow wave or "deep" sleep, in older adults with osteoarthritis (OA) and insomnia reduces pain sensitivity and inflammatory responses to pain, and improves OA-related pain.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Therapy for Insomnia
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Slow Wave Sleep and Inflammatory Processes in Pain
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Jul 1, 2015
Actual Study Completion Date :
Aug 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Insomnia treatment

Cognitive Behavioral Therapy for Insomnia

Behavioral: Cognitive Behavioral Therapy for Insomnia
6-week behavioral treatment for insomnia

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in minutes of time in slow wave sleep [baseline and 10 weeks]

  2. Change from baseline in relative power of delta EEG activity to index slow wave sleep activity [baseline and 10 weeks]

  3. Change from baseline in nociception flexion reflex threshold [baseline and 10 weeks]

  4. Change from baseline in electrocutaneous pain threshold [baseline and 10 weeks]

  5. Change from baseline in inflammatory cytokine responses to pain [baseline and 10 weeks]

  6. Change from baseline in Western Ontario and McMaster University OA Index [baseline and 10 weeks]

  7. Change from baseline in Knee Pain Scale score [baseline and 10 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 50-75 years of age (for women, post-menopausal)

  • Kellgren-Lawrence grade II radiographic evidence of OA affecting one or both knees

  • knee pain on most days for ≥ 6 months

  • self-reported disability due to knee pain for ≥ 2 of the following: walking, kneeling, ascending or descending stairs, or performing daily activities

  • willing and able to avoid all prescription and non-prescription, non-opiate pain medication for 48 hours prior to testing and all narcotic pain medication for 2 weeks prior to testing

  • meets research diagnostic criteria for sleep maintenance insomnia

Exclusion Criteria:
  • health conditions with immunological components or undergoing or taking immunosuppressive therapies

  • conditions contraindicated for or potentially limiting ability to conduct NFR and/or cold pressor test (e.g. Raynaud's syndrome; seizures; prior MI; respiratory conditions; leg/hip nerve damage; BMI ≥ 32)

  • sleep disorders other than insomnia

  • dementia or cognitive impairment

  • history of schizophrenia or bipolar I disorder; current or recent history (within 3 months) of major psychiatric disorders

  • current depressive symptomatology or current suicidality

  • active substance dependence

  • untreated hypertension

  • use of antidepressants (stable use for 3 months okay), antipsychotics, mood stabilizers, sedative-hypnotics, opiate analgesics

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Rochester Medical Center Rochester New York United States 14642

Sponsors and Collaborators

  • University of Rochester
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Kathi L. Heffner, PhD, University of Rochester
  • Principal Investigator: Wilfred Pigeon, PhD, University of Rochester

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kathi Heffner, Associate Professor of Psychiatry, University of Rochester
ClinicalTrials.gov Identifier:
NCT01683799
Other Study ID Numbers:
  • RSRB00044088
  • R21AG041942-01A1
First Posted:
Sep 12, 2012
Last Update Posted:
Sep 30, 2016
Last Verified:
Sep 1, 2016
Keywords provided by Kathi Heffner, Associate Professor of Psychiatry, University of Rochester
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 30, 2016